Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.
(2004) In Journal of Clinical Rheumatology 10(3). p.155-155
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/162324
- author
- Wollheim, Frank LU
- organization
- publishing date
- 2004
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Rheumatology
- volume
- 10
- issue
- 3
- pages
- 155 - 155
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- wos:000222280300015
- scopus:3042638778
- ISSN
- 1536-7355
- language
- English
- LU publication?
- yes
- id
- 83d4cefc-a4bf-438a-92ba-dbad567e453a (old id 162324)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17043493&dopt=Abstract
- date added to LUP
- 2016-04-01 16:22:54
- date last changed
- 2022-02-12 21:46:39
@article{83d4cefc-a4bf-438a-92ba-dbad567e453a,
author = {{Wollheim, Frank}},
issn = {{1536-7355}},
language = {{eng}},
number = {{3}},
pages = {{155--155}},
publisher = {{Lippincott Williams & Wilkins}},
series = {{Journal of Clinical Rheumatology}},
title = {{Is Rituximab a Potential New Therapy in Systemic Sclerosis?: New Evidence Indicates the Presence of CD20-Positive B-lymphocytes in Scleroderma Skin.}},
url = {{http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17043493&dopt=Abstract}},
volume = {{10}},
year = {{2004}},
}